CSIMarket
 
Semler Scientific inc   (NASDAQ: SMLR)
 

Semler Scientific Inc's Customers Performance

SMLR



 
SMLR's Source of Revenues During the corresponding time, Semler Scientific Inc saw a revenue deteriorated by -44.56 % year on year, sequentially revenue fell by -8.84 %. While revenue at the Semler Scientific Inc 's corporate clients

List of SMLR Customers




for the same period Semler Scientific Inc revnue deteriorated by -44.56 % year on year, sequentially revenue fell by -8.84 %.

List of SMLR Customers

Semler Scientific Inc's Business Units
Variable-fee licenses    15.08 % of total Revenue
Hardware equipment and accessories    1.29 % of total Revenue
Single reportable segment    100 % of total Revenue






Semler Scientific Inc's Comment on Sales, Marketing and Customers



The company provides a patented and FDA-cleared product called QuantaFlo, which measures arterial blood flow to assist in diagnosing peripheral artery disease (PAD). They are pursuing expanded FDA clearance for QuantaFlo to diagnose additional cardiovascular diseases. The company's primary operational focus is its healthcare technology solutions business, which delivers information to support patient care decisions.


  News about Semler Scientific inc Contracts

Legal Alert Semler Scientific Investors Urged to Act Ahead of Class Action Deadline

New York, September 22, 2025 Levi and Korsinsky, LLP, a nationally recognized law firm specializing in securities litigation, has issued a notification to investors of Semler Scientific, Inc. (Semler) regarding an ongoing class action lawsuit. Semler, which is listed on NASDAQ under the ticker symbol SMLR, is currently embroiled in legal proceedings that concern alleged securities violations. Background and Context: The class action suit represents a significant legal challenge for the California-based company that specializes in the development and sale of software solutions for chronic disease assessment. As a key player in the medical technology sector, Semler s products are widely used to enhance p...




Semler Scientific Inc’s Comment on Sales, Marketing and Customers


The company provides a patented and FDA-cleared product called QuantaFlo, which measures arterial blood flow to assist in diagnosing peripheral artery disease (PAD). They are pursuing expanded FDA clearance for QuantaFlo to diagnose additional cardiovascular diseases. The company's primary operational focus is its healthcare technology solutions business, which delivers information to support patient care decisions.








SMLR's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Semler Scientific inc 336.36 36.96 48.34 31
SUBTOTAL 0.00 0.00 0.00 -

Sources: Semler Scientific inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Semler Scientific inc’s corporate clients.
For your research, we’ve provided 9 tables on Semler Scientific inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.